Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
NAV28/05/2024 | Chg.-10.4700 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
2,023.7700EUR | -0.51% | reinvestment | Equity Worldwide | Candriam ▶ |
NAV28/05/2024 | Chg.-10.4700 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
2,023.7700EUR | -0.51% | reinvestment | Equity Worldwide | Candriam ▶ |